PL1802302T3 - NOWE ZASTOSOWANIE alfa-SYMPATYKOMIMETYKÓW MAJĄCYCH STRUKTURĘ 2-IMIDAZOLINOWĄ - Google Patents

NOWE ZASTOSOWANIE alfa-SYMPATYKOMIMETYKÓW MAJĄCYCH STRUKTURĘ 2-IMIDAZOLINOWĄ

Info

Publication number
PL1802302T3
PL1802302T3 PL05784163T PL05784163T PL1802302T3 PL 1802302 T3 PL1802302 T3 PL 1802302T3 PL 05784163 T PL05784163 T PL 05784163T PL 05784163 T PL05784163 T PL 05784163T PL 1802302 T3 PL1802302 T3 PL 1802302T3
Authority
PL
Poland
Prior art keywords
sympathomimetics
alpha
novel use
imidazoline structure
imidazoline
Prior art date
Application number
PL05784163T
Other languages
English (en)
Inventor
Fritz Sacher
Marion Tschaikin
Stephan Koelsch
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35276675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1802302(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL1802302T3 publication Critical patent/PL1802302T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL05784163T 2004-10-05 2005-09-16 NOWE ZASTOSOWANIE alfa-SYMPATYKOMIMETYKÓW MAJĄCYCH STRUKTURĘ 2-IMIDAZOLINOWĄ PL1802302T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004049008A DE102004049008A1 (de) 2004-10-05 2004-10-05 Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
EP05784163.7A EP1802302B1 (de) 2004-10-05 2005-09-16 NEUE VERWENDUNG FÜR alpha-SYMPATHOMIMETIKA MIT 2-IMIDAZOLINSTRUKTUR

Publications (1)

Publication Number Publication Date
PL1802302T3 true PL1802302T3 (pl) 2017-08-31

Family

ID=35276675

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05784163T PL1802302T3 (pl) 2004-10-05 2005-09-16 NOWE ZASTOSOWANIE alfa-SYMPATYKOMIMETYKÓW MAJĄCYCH STRUKTURĘ 2-IMIDAZOLINOWĄ

Country Status (20)

Country Link
US (1) US20080108685A1 (pl)
EP (1) EP1802302B1 (pl)
JP (1) JP5311825B2 (pl)
KR (1) KR20070059134A (pl)
CN (1) CN101022797B (pl)
AU (1) AU2005291603B2 (pl)
BR (1) BRPI0516832A (pl)
CA (1) CA2582984C (pl)
CY (1) CY1118581T1 (pl)
DE (1) DE102004049008A1 (pl)
DK (1) DK1802302T3 (pl)
ES (1) ES2612544T3 (pl)
HU (1) HUE031515T2 (pl)
LT (1) LT1802302T (pl)
MX (1) MX2007004040A (pl)
PL (1) PL1802302T3 (pl)
PT (1) PT1802302T (pl)
RU (1) RU2397764C2 (pl)
WO (1) WO2006037452A1 (pl)
ZA (1) ZA200703622B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004049008A1 (de) 2004-10-05 2006-04-06 Merck Patent Gmbh Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
US12343427B1 (en) * 2024-04-23 2025-07-01 Nivagen Pharmaceuticals, Inc. Stable intravenous diltiazem hydrochloride formulation and use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2137981T3 (es) 1991-11-19 2000-01-01 Univ Virginia Tratamiento combinado por agentes antimediaticos y antiviricos de resfriados comunes.
JPH06211659A (ja) * 1993-01-19 1994-08-02 Kowa Co 点鼻薬組成物
US5576437A (en) 1993-12-17 1996-11-19 The Procter & Gamble Company 7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists
DE4438589A1 (de) 1994-10-28 1995-03-23 Reingard Dr Muenster Nasentherapeutikum
WO1996025163A1 (en) * 1995-02-14 1996-08-22 Board Of Supervisors Or Louisiana State Universityof Agricultural And Mechanical College Through Itsmedical Center Treatment of herpes simplex viruses
US5916900A (en) * 1995-06-29 1999-06-29 The Procter & Gamble Company 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
DE19541919C2 (de) 1995-11-10 1997-11-20 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
EP1326642A2 (en) 2000-09-29 2003-07-16 Board of Trustees operating Michigan State University Catecholamine pharmaceutical compositions and methods
DE60209511T2 (de) * 2001-09-18 2006-10-05 Nycomed Danmark Aps Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
RU2220739C1 (ru) * 2002-08-30 2004-01-10 Гапонюк Петр Яковлевич Интраназальное средство
DE10250944B9 (de) 2002-10-31 2004-09-16 Cell Center Cologne Gmbh Verwendung eines Stifts zur Applikation von Pflege- oder Wirkstoffen in die Nase
DE102004049008A1 (de) 2004-10-05 2006-04-06 Merck Patent Gmbh Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur

Also Published As

Publication number Publication date
US20080108685A1 (en) 2008-05-08
RU2397764C2 (ru) 2010-08-27
EP1802302B1 (de) 2016-10-26
AU2005291603B2 (en) 2010-10-14
DK1802302T3 (en) 2017-02-06
KR20070059134A (ko) 2007-06-11
BRPI0516832A (pt) 2008-09-23
HUE031515T2 (en) 2017-07-28
MX2007004040A (es) 2007-05-24
PT1802302T (pt) 2017-02-07
WO2006037452A1 (de) 2006-04-13
EP1802302A1 (de) 2007-07-04
RU2007116719A (ru) 2008-11-20
AU2005291603A1 (en) 2006-04-13
JP2008515824A (ja) 2008-05-15
CY1118581T1 (el) 2017-07-12
JP5311825B2 (ja) 2013-10-09
CA2582984C (en) 2012-06-05
DE102004049008A1 (de) 2006-04-06
CN101022797A (zh) 2007-08-22
ES2612544T3 (es) 2017-05-17
ZA200703622B (en) 2008-08-27
LT1802302T (lt) 2017-02-10
CN101022797B (zh) 2010-12-15
CA2582984A1 (en) 2006-04-13

Similar Documents

Publication Publication Date Title
PL3281939T3 (pl) Kombinacja zawierająca trwały kryształ związku 4-oksochinolinowego
IL178029A0 (en) Use of sulfonylureas
GB0404124D0 (en) Antagonists of GIP
GB0504995D0 (en) Use of a compound
EP1806147A4 (en) USE OF IMMUNOSUPPRESSIVE RECEPTOR
PL1763520T3 (pl) Zastosowanie tripodstawionych benzopiranonów
GB0417587D0 (en) Conformable structures
ZA200703622B (en) Novel use of α-sympathomlmetics having a 2-imidazoline structure
PL1705998T3 (pl) Zastosowanie karboksypeptydazy
GB0410554D0 (en) A crutch
GB0711875D0 (en) Use of a cloth
AU158223S (en) Wristwatch
GB0424405D0 (en) A structure
EP1739134A4 (en) COMPOST AZO
AU157395S (en) A set of hangers
GB0427206D0 (en) A bath
GB2425472B (en) A shower construction
GB0522829D0 (en) Use of a compound
AU157616S (en) A set of furniture
GB2416051B (en) Selection of component
AU156767S (en) A set of sinks
AU157008S (en) A set of street furniture
AU157009S (en) A set of street furniture
AU157010S (en) A set of street furniture
PL369353A1 (pl) Zestaw elementów budowlanych